Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Gynecol Oncol. 2013 Oct 4;131(3):535–540. doi: 10.1016/j.ygyno.2013.09.032

Table 3.

Hematologic and Non-hematologic Toxicities

Toxicity Grade 1 Grade 2 Grade 3 Grade 4 Grade 5

No. of Patients % No. of Patients % No. of Patients % No. of Patients % No. of Patients %
Anemia 18 82 5 15 5 15 0 0
Leukopenia 11 32 8 24 5 15 4 12 0
Thrombocytopenia 11 32 0 1 3 3 9 0
Neutropenia 13 38 4 12 6 18 10 29 0
Allergy 10 29 1 3 0 0 0
Auditory 1 3 0 0 0 0
Cardiovascular 5 15 5 15 1 3 0 0
Impaired coagulation 4 12 0 2 6 0 0
Constitutional 9 26 17 50 5 15 0 1 3
Rash 12 35 11 32 0 0 0
Endocrine 0 1 3 0 0 0
Hyperbilirubinemia 0 0 0 0 0
Gastrointestinal 12 35 15 44 4 12 0 0
Genitourinary 1 3 3 9 2 6 0 0
Hemorrhage 3 9 0 1 3 0 0
Infection/Febrile Neutropenia 3 9 10 29 0 1 3 0
Lymphatics 0 0 1 3 0 0 0
Metabolic 12 35 11 32 7 21 1 3 0
Musculoskeletal 1 3 0 1 3 0 0
Neurologic 8 24 12 6 1 3 0 0
Ocular 6 18 0 0 0 0
Pain 5 15 17 50 6 18 1 3 0
Pulmonary 8 24 8 24 0 0 0
Vascular 0 1 3 2 6 0 0